Orgenesis Inc
Change company Symbol lookup
Select an option...
ORGS Orgenesis Inc
LYFT Lyft Inc
AROC Archrock Inc
PACK Ranpak Holdings Corp
NVEE NV5 Global Inc
YARIY Yara International ASA
HYB New America High Income Fund
ACV Virtus Diversified Income & Convertible Fund
XLO Xilio Therapeutics Inc
ORN Orion Group Holdings Inc
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

Orgenesis Inc. is a global biotech company that is operating to unlock the potential of cell and gene therapies (CGTs). The Company is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). It has developed a Point of Care Platform (POCare Platform) comprised of three enabling components, which includes a pipeline of POCare advanced therapies that are designed to be processed and produced, automated closed POCare technology systems, and a worldwide network of POCare research institutes and hospitals (POCare Network). Its products in clinical use include KYSLECEL, Tissue Genesis Icellator for Cell Assisted Lipotransfer, Cartil-S Autologous products for the treatment of osteoarthritis, and Chondroseal Autologous products for the treatment of cartilage defects.

Closing Price
$2.52
Day's Change
0.13 (5.44%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.54
Day's Low
2.45
Volume
(Light)
Volume:
23,051

10-day average volume:
35,350
23,051

Paramount Global and Citi surge after Berkshire Hathaway discloses new stakes

8:44 am ET May 17, 2022 (MarketWatch)
Print

Three of the new positions revealed in Berkshire Hathaway's (BRKA)13-F filing jumped in premarket trade on Tuesday. Paramount Global's B shares (PARA) bounced 10%, as Celanese (CE) rose 6% and Citigroup (C) rose 5%. Investors had already known that Warren Buffett's investment vehicle had invested heavily in Occidental Petroleum (OXY), Chevron (CVX) and HP (HPQ) during the first quarter.

-Steve Goldstein

	

(END) Dow Jones Newswires

May 17, 2022 08:44 ET (12:44 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.